Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.11) by 9.09 percent. This is a 40 percent increase over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $3.38 million which missed the analyst consensus estimate of $4.62 million by 27.02 percent. This is a 10.14 percent decrease over sales of $3.76 million the same period last year.